TRIM21 was identified as a major autoantigen in autoimmune diseases including Sjögren's syndrome, systemic lupus erythematosus (SLE), and rheumatoid arthritis [70–72]. This evidence concerns the gene TRIM21 and systemic lupus erythematosus.